J Breast Cancer.  2017 Mar;20(1):114-115. 10.4048/jbc.2017.20.1.114.

Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer”

• Altundag K

• KMID: 2379408
• DOI: http://doi.org/10.4048/jbc.2017.20.1.114

Abstract

No abstract available.

MeSH Terms

Breast*
Drug Therapy*

Reference

1. Jung YY, Hyun CL, Jin MS, Park IA, Chung YR, Shim B, et al. Histomorphological factors predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. J Breast Cancer. 2016; 19:261–267.

2. Erbes T, Stickeler E, Rücker G, Buroh S, Asberger J, Dany N, et al. BMI and pathologic complete response to neoadjuvant chemotherapy in breast cancer: a study and meta-analysis. Clin Breast Cancer. 2016; 16:e119–e132.